{"pmcid": 4033571, "prompt_strategy": "zeroshot", "model": "gpt-5.1", "extractions": [{"outcome": "Overall seizure median percent improvement", "intervention": "Extended-release oxcarbazepine 2400 mg", "comparator": "Control", "intervention_group_size": 111, "comparator_group_size": 117, "intervention_mean": 42.9, "comparator_mean": 28.7, "outcome_type": "continuous"}, {"outcome": "Adverse effects", "intervention": "Extended-release oxcarbazepine 1200 mg", "comparator": "Control", "intervention_group_size": 122, "comparator_group_size": 121, "intervention_events": 69, "comparator_events": 67, "outcome_type": "binary"}, {"outcome": "Overall seizure median percent reduction", "intervention": "Extended-release oxcarbazepine 1200 mg", "comparator": "Control", "intervention_group_size": 109, "comparator_group_size": 117, "intervention_mean": 38.2, "comparator_mean": 28.7, "outcome_type": "continuous"}, {"outcome": "Adverse effects", "intervention": "Extended-release oxcarbazepine 2400 mg", "comparator": "Control", "intervention_group_size": 123, "comparator_group_size": 121, "intervention_events": 85, "comparator_events": 67, "outcome_type": "binary"}, {"outcome": "Seizure median percent improvement in North America", "intervention": "Extended-release oxcarbazepine 1200 mg", "comparator": "Control", "intervention_group_size": 40, "comparator_group_size": 41, "intervention_mean": 34.5, "comparator_mean": 13.3, "outcome_type": "continuous"}, {"outcome": "Seizure median percent improvement in North America", "intervention": "Extended-release oxcarbazepine 2400 mg", "comparator": "Control", "intervention_group_size": 35, "comparator_group_size": 41, "intervention_mean": 52.7, "comparator_mean": 13.3, "outcome_type": "continuous"}], "errors": []}
